Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2021

 

Upgrades

  • For Lowe's Companies Inc LOW, Gordon Haskett upgraded the previous rating of Accumulate to Buy. Lowe's Companies earned $1.33 in the fourth quarter, compared to $0.94 in the year-ago quarter. At the moment, the stock has a 52-week-high of $180.67 and a 52-week-low of $60.00. Lowe's Companies closed at $162.00 at the end of the last trading period.
  • According to Guggenheim, the prior rating for Square Inc SQ was changed from Neutral to Buy. For the fourth quarter, Square had an EPS of $0.32, compared to year-ago quarter EPS of $0.23. The stock has a 52-week-high of $283.19 and a 52-week-low of $32.33. At the end of the last trading period, Square closed at $237.32.
  • HSBC upgraded the previous rating for Nike Inc NKE from Hold to Buy. For the second quarter, Nike had an EPS of $0.78, compared to year-ago quarter EPS of $0.70. The current stock performance of Nike shows a 52-week-high of $147.95 and a 52-week-low of $60.00. Moreover, at the end of the last trading period, the closing price was at $135.56.
  • For TrueCar Inc TRUE, Benchmark upgraded the previous rating of Hold to Buy. For the fourth quarter, TrueCar had an EPS of $0.01, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $6.47 and a 52-week-low of $1.98. At the end of the last trading period, TrueCar closed at $5.06.
  • For Ardagh Group SA ARD, Wells Fargo upgraded the previous rating of Underweight to Overweight. For the fourth quarter, Ardagh Group had an EPS of $0.28, compared to year-ago quarter EPS of $0.39. At the moment, the stock has a 52-week-high of $24.70 and a 52-week-low of $9.20. Ardagh Group closed at $23.26 at the end of the last trading period.
  • Credit Suisse upgraded the previous rating for Evoqua Water Technologies Corp AQUA from Neutral to Outperform. For the first quarter, Evoqua Water Technologies had an EPS of $0.06, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $31.63 and a 52-week-low of $7.08. At the end of the last trading period, Evoqua Water Technologies closed at $24.66.
  • According to UBS, the prior rating for AstraZeneca PLC AZN was changed from Neutral to Buy. In the fourth quarter, AstraZeneca showed an EPS of $0.54, compared to $0.45 from the year-ago quarter. The current stock performance of AstraZeneca shows a 52-week-high of $64.94 and a 52-week-low of $36.15. Moreover, at the end of the last trading period, the closing price was at $50.10.
  • Credit Suisse upgraded the previous rating for Sunrun Inc RUN from Neutral to Outperform.  At the moment, the stock has a 52-week-high of $100.93 and a 52-week-low of $7.83. Sunrun closed at $62.56 at the end of the last trading period.

See all analyst ratings upgrades.

 

Downgrades

  • Stifel downgraded the previous rating for Photronics Inc PLAB from Buy to Hold. For the first quarter, Photronics had an EPS of $0.13, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $13.65 and a 52-week-low of $8.31. At the end of the last trading period, Photronics closed at $13.38.
  • Gordon Haskett downgraded the previous rating for TJX Companies Inc TJX from Buy to Hold. In the fourth quarter, TJX Companies showed an EPS of $0.50, compared to $0.81 from the year-ago quarter. At the moment, the stock has a 52-week-high of $71.06 and a 52-week-low of $32.72. TJX Companies closed at $69.72 at the end of the last trading period.
  • For Cimarex Energy Co XEC, MKM Partners downgraded the previous rating of Buy to Neutral. In the fourth quarter, Cimarex Energy showed an EPS of $0.89, compared to $1.18 from the year-ago quarter. At the moment, the stock has a 52-week-high of $61.60 and a 52-week-low of $12.15. Cimarex Energy closed at $60.80 at the end of the last trading period.
  • For Norfolk Southern Corp NSC, Evercore ISI Group downgraded the previous rating of Outperform to In-Line. Norfolk Southern earned $2.64 in the fourth quarter, compared to $2.55 in the year-ago quarter. The current stock performance of Norfolk Southern shows a 52-week-high of $264.11 and a 52-week-low of $112.62. Moreover, at the end of the last trading period, the closing price was at $261.53.
  • For Canadian Pacific Railway Ltd CP, Evercore ISI Group downgraded the previous rating of Outperform to In-Line. In the fourth quarter, Canadian Pacific Railway showed an EPS of $3.90, compared to $4.77 from the year-ago quarter. At the moment, the stock has a 52-week-high of $379.00 and a 52-week-low of $173.26. Canadian Pacific Railway closed at $365.63 at the end of the last trading period.
  • For Epizyme Inc EPZM, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. For the fourth quarter, Epizyme had an EPS of $0.65, compared to year-ago quarter EPS of $0.59. The stock has a 52-week-high of $23.61 and a 52-week-low of $9.90. At the end of the last trading period, Epizyme closed at $10.19.
  • For NeoGenomics Inc NEO, Raymond James downgraded the previous rating of Outperform to Market Perform. In the fourth quarter, NeoGenomics showed an EPS of $0.14, compared to $0.10 from the year-ago quarter. The current stock performance of NeoGenomics shows a 52-week-high of $61.57 and a 52-week-low of $20.47. Moreover, at the end of the last trading period, the closing price was at $54.34.
  • According to Oppenheimer, the prior rating for AT&T Inc T was changed from Outperform to Perform. AT&T earned $0.75 in the fourth quarter, compared to $0.89 in the year-ago quarter. The stock has a 52-week-high of $38.51 and a 52-week-low of $26.08. At the end of the last trading period, AT&T closed at $29.41.
  • Oppenheimer downgraded the previous rating for Verizon Communications Inc VZ from Outperform to Perform. For the fourth quarter, Verizon Communications had an EPS of $1.21, compared to year-ago quarter EPS of $1.13. At the moment, the stock has a 52-week-high of $61.95 and a 52-week-low of $48.84. Verizon Communications closed at $57.13 at the end of the last trading period.
  • For Zymeworks Inc ZYME, SVB Leerink downgraded the previous rating of Outperform to Market Perform. In the fourth quarter, Zymeworks showed an EPS of $0.74, compared to $1.06 from the year-ago quarter. The current stock performance of Zymeworks shows a 52-week-high of $59.03 and a 52-week-low of $20.33. Moreover, at the end of the last trading period, the closing price was at $40.30.
  • Credit Suisse downgraded the previous rating for Pinnacle West Capital Corp PNW from Outperform to Neutral. For the fourth quarter, Pinnacle West Capital had an EPS of $0.17, compared to year-ago quarter EPS of $0.57. At the moment, the stock has a 52-week-high of $103.31 and a 52-week-low of $60.05. Pinnacle West Capital closed at $73.11 at the end of the last trading period.
  • According to Credit Suisse, the prior rating for Ping Identity Holding Corp PING was changed from Outperform to Neutral. In the fourth quarter, Ping Identity Holding showed an EPS of $0.09, compared to $0.14 from the year-ago quarter. The stock has a 52-week-high of $37.80 and a 52-week-low of $12.02. At the end of the last trading period, Ping Identity Holding closed at $32.52.
  • According to Credit Suisse, the prior rating for Lennox International Inc LII was changed from Neutral to Underperform. In the fourth quarter, Lennox International showed an EPS of $2.89, compared to $2.45 from the year-ago quarter. The stock has a 52-week-high of $319.77 and a 52-week-low of $163.40. At the end of the last trading period, Lennox International closed at $290.74.
  • According to Piper Sandler, the prior rating for Tabula Rasa HealthCare Inc TRHC was changed from Overweight to Neutral. For the fourth quarter, Tabula Rasa HealthCare had an EPS of $0.08, compared to year-ago quarter EPS of $0.13. The stock has a 52-week-high of $69.31 and a 52-week-low of $30.12. At the end of the last trading period, Tabula Rasa HealthCare closed at $45.65.

See all analyst ratings downgrades.

 

Initiations

  • Stifel initiated coverage on Precigen Inc PGEN with a Buy rating. The price target for Precigen is set to $13.00. For the third quarter, Precigen had an EPS of $0.18, compared to year-ago quarter EPS of $0.34. At the moment, the stock has a 52-week-high of $11.10 and a 52-week-low of $1.26. Precigen closed at $8.57 at the end of the last trading period.
  • Piper Sandler initiated coverage on I-MAB IMAB with an Overweight rating. The price target for I-MAB is set to $75.00. NoneAt the moment, the stock has a 52-week-high of $65.55 and a 52-week-low of $11.05. I-MAB closed at $57.99 at the end of the last trading period.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!